Letters & Testimony
Letter to FDIC et al from PIRG and SBPC concerning a “junk fee bonanza”
Testimony- Credit Scoring and FCRA: How mistakes affect credit reports
Proliferation of medical credit cards raise concerns about increasing medical debt
Comment letter on misuse of “FDIC-Insured” in advertising
Why health care is unaffordable – U.S. PIRG testimony for House Ways & Means Committee, Subcommittee on Health hearing:
Recommendations on how the U.S. Patent and Trademarks Office can improve access to generic drugs
U.S. PIRG submitted recommendations in response to a Request for Comments from the U.S Patent and Trademark Office related to agency initiatives to ensure the robustness and reliability of patent rights.
Group letter to Congress opposing rollback of state privacy and other consumer laws
Financial privacy bill in Congress would eliminate strong state laws
PIRG urges agencies to break down barriers to generic drugs
Advocates for regulatory changes to end anti-competitive practices and patent abuse to bring lower-cost generic drugs to pharmacy shelves sooner.